4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-020777
Options or other derivatives
- Director acquired 41,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dubin Glenn Director | 2021-03-12 | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…